Kerstin Lippl
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Biochemical and biophysical analyses of hypoxia sensing prolyl hydroxylases from Dictyostelium discoideum and Toxoplasma gondii.
Journal: The Journal of biological chemistry
Published: April 22, 2020
The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases.
Journal: ACS chemical biology
Published: July 10, 2019
Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates.
Journal: eLife
Published: February 28, 2019
Born to sense: biophysical analyses of the oxygen sensing prolyl hydroxylase from the simplest animal Trichoplax adhaerens.
Journal: Hypoxia (Auckland, N.Z.)
Published: December 07, 2018
Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors.
Journal: MedChemComm
Published: November 05, 2018
Studies on the Substrate Selectivity of the Hypoxia-Inducible Factor Prolyl Hydroxylase 2 Catalytic Domain.
Journal: Chembiochem : a European journal of chemical biology
Published: May 08, 2018
2-Oxoglutarate regulates binding of hydroxylated hypoxia-inducible factor to prolyl hydroxylase domain 2.
Journal: Chemical communications (Cambridge, England)
Published: March 10, 2018
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials.
Journal: Chemical science
Published: May 10, 2017
Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases.
Journal: The Journal of biological chemistry
Published: July 20, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026